Last reviewed · How we verify

NCT06247371

Impact of a Novel Heart Failure Medication Decision Aid

Completed NA Last updated 11 February 2025
What this trial tests

NA trial testing Decision aid in Heart Failure in 150 participants. Completed in 10 February 2025.

Timeline
9 April 2024
Primary endpoint
25 July 2024
10 February 2025

Quick facts

Lead sponsorNational University of Singapore
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment150
Start date9 April 2024
Primary completion25 July 2024
Estimated completion10 February 2025
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National University of Singapore

Who can join

22 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A modified Zelen design randomised controlled trial over 6 months period is designed to investigate the influence of a heart failure medication decision aid prior to clinic session on shared decision making and its long term effect. Participants are randomised to either the decision aid arm or the usual care arm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Decision aid

Trials testing the same drug.

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other National University of Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06247371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing